[TheMechanist]

Gentlemen, the hole is due to the fact that no company has the large scale productive capacity for the newly discovered COVID-19 vaccine.

Ordering earlier and paying more would just have shifted distribution around, and would not have made more doses available. Every vaccination done in the US or the UK means one less vaccine dose for Europe.

And that is not "ducking responsibility", it is basic logic - as one cannot fit 10 pegs in 9 holes, one cannot vaccinate 10 people with 9 doses.

[anonuser123456]

Your model seems to assume a fixed production capacity? It would seem plausible that if you paid an extra billion or two, companies could find a way to scale up production faster.

[mauritzio]

Well the fact that the companies own the stuff that was researched with tax payer money, which then tax payer money must buy again also doesn't help to scale. As there is no real market but just an oligopol of producers. If the formulas would be public domain, the producers can compete who is fastest and there would be much more and they still earn good money...